Pathstone Holdings, LLC Neogenomics Inc Transaction History
Pathstone Holdings, LLC
- $22.3 Billion
- Q3 2024
A detailed history of Pathstone Holdings, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Pathstone Holdings, LLC holds 32,419 shares of NEO stock, worth $532,644. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,419
Previous 33,099
2.05%
Holding current value
$532,644
Previous $459,000
4.14%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding NEO
# of Institutions
278Shares Held
125MCall Options Held
581KPut Options Held
115K-
Black Rock Inc. New York, NY19.7MShares$323 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$231 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$113 Million0.13% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.73MShares$111 Million0.06% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$108 Million0.05% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $2.07B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...